Data / Drug companies / Cardinal Health 110, LLC. DBA Leader
Cardinal Health 110, LLC. DBA Leader: 400 products in the FDA NDC directory, labeler code 70000
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Cardinal Health 110, LLC. DBA Leader (labeler code 70000) lists 400 products in the FDA National Drug Code Directory, covering 201 finished drugs by generic name. By type: 400 over the counter drugs. Its main marketing category is over the counter monograph drugs. The newest product started marketing on October 30, 2026.
The request: Watch Cardinal Health 110, LLC. DBA Leader (FDA labeler code 70000): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 70000
- Products in commercial distribution
- 400
- Packages
- 514
- Finished drugs by generic name
- 201
- Prescription products
- 0
- Over the counter products
- 400
- Flagged as original packager
- 345 of 345 products that carry the flag
- Started marketing in the last 12 months
- 27
- Products with a marketing end date set
- 36
- Earliest marketing start
- March 2, 1990
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Over the counter monograph drugs | 269 | 67.2% |
| Generic drugs (ANDA) | 118 | 29.5% |
| New drug applications (NDA) | 9 | 2.2% |
| Other unapproved drugs | 4 | 1% |
Products by type
| Type | Products | Share |
|---|---|---|
| Over the counter drugs | 400 | 100% |
Drugs it lists
Finished drugs by generic name, with how many companies list each.
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet, film coated | 47 | 11.8% |
| Liquid | 39 | 9.8% |
| Tablet | 33 | 8.2% |
| Solution | 27 | 6.8% |
| Tablet, chewable | 22 | 5.5% |
| Cream | 20 | 5% |
| Ointment | 19 | 4.8% |
| Suspension | 18 | 4.5% |
| Solution/ drops | 17 | 4.2% |
| Capsule, liquid filled | 14 | 3.5% |
| Spray | 11 | 2.8% |
| Patch | 10 | 2.5% |
Pharmacologic classes
FDA established pharmacologic classes of its products.
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Headache Relief | 70000-0777 | Tablet, film coated | Over the counter monograph drugs | October 30, 2026 |
| Dandruff | 70000-0775 | Lotion/shampoo | Over the counter monograph drugs | September 10, 2026 |
| Therapeutic Dandruff | 70000-0776 | Shampoo | Over the counter monograph drugs | September 2, 2026 |
| Allergy Relief | 70000-0771 | Capsule | Over the counter monograph drugs | August 14, 2026 |
| Leader 12hr allergy and congestion relief | 70000-0772 | Tablet, film coated, extended release | Generic drugs (ANDA) | August 3, 2026 |
| Leader ultra strength | 70000-0773 | Tablet, chewable | Over the counter monograph drugs | July 17, 2026 |
| LEADER No Drip | 70000-0766 | Spray | Over the counter monograph drugs | July 1, 2026 |
| LEADER Multi Symptom Flu Relief Daytime Max Strength | 70000-0764 | Powder, for solution | Over the counter monograph drugs | July 1, 2026 |
| LEADER MS Flu Relief Nighttime | 70000-0763 | Powder, for solution | Over the counter monograph drugs | July 1, 2026 |
| Lubricant Eye | 70000-0751 | Solution/ drops | Over the counter monograph drugs | May 12, 2026 |
| Povidone-Iodine | 70000-0757 | Solution | Over the counter monograph drugs | April 9, 2026 |
| Leader Mucus Relief | 70000-0758 | Tablet, multilayer, extended release | Generic drugs (ANDA) | April 8, 2026 |
| Nicotine Transdermal System step 1 | 70000-0762 | Patch, extended release | New drug applications (NDA) | March 20, 2026 |
| Nicotine Transdermal System step 2 | 70000-0761 | Patch, extended release | New drug applications (NDA) | March 20, 2026 |
| Nicotine Transdermal System step 3 | 70000-0760 | Patch, extended release | New drug applications (NDA) | March 20, 2026 |
| Allergy relief | 70000-0755 | Capsule, liquid filled | Generic drugs (ANDA) | March 18, 2026 |
| Minoxidil for men | 70000-0754 | Aerosol, foam | Generic drugs (ANDA) | March 16, 2026 |
| Minoxidil for women | 70000-0753 | Aerosol, foam | Generic drugs (ANDA) | March 16, 2026 |
| Eye Allergy Itch Relief | 70000-0746 | Solution/ drops | Generic drugs (ANDA) | January 15, 2026 |
| Leader Vapor Ice Cold and Flu | 70000-0747 | Tablet, film coated | Over the counter monograph drugs | January 14, 2026 |
| Docosanol | 70000-0743 | Cream | Generic drugs (ANDA) | December 25, 2025 |
| Motion Sickness Relief | 70000-0749 | Tablet | Over the counter monograph drugs | December 5, 2025 |
| Pain Relieving | 70000-0744 | Cream | Over the counter monograph drugs | December 4, 2025 |
| Cold and Flu Relief Daytime | 70000-0752 | Capsule, liquid filled | Over the counter monograph drugs | December 1, 2025 |
| Triamcinolone Acetonide | 70000-0742 | Spray, metered | Generic drugs (ANDA) | November 26, 2025 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.